Clinical Trial Update: Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation [NA]

View source ↗

Summary

A completed clinical trial evaluated whether empagliflozin reduces oxidative stress in kidney transplant recipients. The study was conducted under Shahid Behesh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Kidney Transplant; Complications | NA | Status: COMPLETED